Figure 1From: Use of comparative effectiveness research for similar Chinese patent medicine for angina pectoris of coronary heart disease: a new approach based on patient-important outcomes Study flowchart. CA, Correspondence analysis; CER, Comparative effectiveness research; MCID, Minimal clinically important difference; PIO, Patient-important outcome; SAQ, Seattle Angina Questionnaire.Back to article page